Amneal Pharmaceuticals advances DHE autoinjector resubmission and secures FDA approval for exenatide
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), has achieved two significant milestones, reinforcing its position in the pharmaceutical industry. The company announced the resubmission of its New ... Read More
Strides Pharma, Amneal Pharmaceuticals partner to launch Icosapent ethyl capsules
Strides Pharma Science Limited (“Strides”) has joined forces with Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) to introduce Icosapent ethyl acid soft gel capsules to the ... Read More